Administration of Bromocriptine by the Vaginal Route in Women Intolerant of Oral Therapy

Abstract

Objective

To assess the use of intravaginal bromocriptine mesylate in women intolerant of orally administered bromocriptine.

Participants

Two consecutive women of reproductive age with prolactin-secreting pituitary microadenomas who were intolerant of oral bromocriptine.

Results

Normoprolactinemia with eumenorrhea was obtained using intravaginal bromocriptine.

Conclusions

Intravaginal bromocriptine is recommended as an alternative route of administration in women intolerant of oral therapy.